OFFICE-BASED METHADONE VS BUPRENORPHINE TO ADDRESS RETENTION IN MEDICATION FOR OPIOID USE DISORDER (MOUD)-A PRAGMATIC HYBRID EFFECTIVENESS/IMPLEMENTAT
$1,026,853N01FY2022DANIH
The Emmes Company, Llc, Rockville MD
Investigators
Abstract
Substance Misuse
View original record on NIH RePORTER →